The anti-cancer effects of IL-2-activated lymphocytes is not new but originally considered clinically relevant for activating patient’s own anti-cancer effector cells in patients with cancer (Mule et al. 1984; Rosenberg et al. 1985; Rosenberg et al. 1987). Here, IL2 is linked to cancer.